Evidence map›Paper›PMID 39111359›Full record

ArticleNature2024

A virally encoded tRNA neutralizes the PARIS antiviral defence system.

Nathaniel Burman, Svetlana Belukhina, Florence Depardieu, Royce A Wilkinson, Mikhail Skutel, Andrew Santiago-Frangos, Ava B Graham, Alexei Livenskyi, Anna Chechenina, Natalia Morozova and 17 more

Erratum issuedAbstract read
In one paragraph

Article in Nature, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 57 papers.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed.

  1. How bacterial immune systems sense phage infection.Nature reviews. Microbiology · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. The halophilic archaeonMicrobiology spectrum · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. DNA-intercalating antiphage molecules trigger abortive infection through mutual destruction and synergize with bacterial immunity.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

27 authors.

Nathaniel Burman *Department of Microbiology and Cell Biology, Montana State University, Bozeman, MT, USA.ORCID 0000-0002-3732-3159
Svetlana Belukhina *The Center for Molecular and Cellular Biology, Moscow, Russia.
Florence Depardieu *Synthetic Biology, Institut Pasteur, Université Paris Cité, CNRS UMR 6047, Paris, France.
Royce A WilkinsonDepartment of Microbiology and Cell Biology, Montana State University, Bozeman, MT, USA.ORCID 0000-0001-8831-2081
Mikhail SkutelThe Center for Molecular and Cellular Biology, Moscow, Russia.ORCID 0009-0002-1351-3238
Andrew Santiago-FrangosDepartment of Microbiology and Cell Biology, Montana State University, Bozeman, MT, USA.ORCID 0000-0001-9615-065X
Ava B GrahamDepartment of Microbiology and Cell Biology, Montana State University, Bozeman, MT, USA.
Alexei LivenskyiCenter for Precision Genome Editing and Genetic Technologies for Biomedicine, Institute of Gene Biology, Russian Academy of Sciences, Moscow, Russia.
Anna ChecheninaThe Center for Molecular and Cellular Biology, Moscow, Russia.
Natalia MorozovaPeter the Great St Petersburg State Polytechnic University, St. Petersburg, Russia.
Trevor ZahlDepartment of Microbiology and Cell Biology, Montana State University, Bozeman, MT, USA.
William S HenriquesDepartment of Microbiology and Cell Biology, Montana State University, Bozeman, MT, USA.
Murat BuyukyorukDepartment of Microbiology and Cell Biology, Montana State University, Bozeman, MT, USA.
Christophe RouillonSynthetic Biology, Institut Pasteur, Université Paris Cité, CNRS UMR 6047, Paris, France.ORCID 0000-0003-4038-315X
Baptiste SaudemontSynthetic Biology, Institut Pasteur, Université Paris Cité, CNRS UMR 6047, Paris, France.
Lena ShyrokovaDepartment of Experimental Medical Science, Lund University, Lund, Sweden.ORCID 0000-0002-0361-6359
Tatsuaki KurataDepartment of Experimental Medical Science, Lund University, Lund, Sweden.
Vasili HauryliukDepartment of Experimental Medical Science, Lund University, Lund, Sweden.ORCID 0000-0003-2389-5057
Konstantin SeverinovCenter for Precision Genome Editing and Genetic Technologies for Biomedicine, Institute of Gene Biology, Russian Academy of Sciences, Moscow, Russia.
Justine GroseilleUnité Régulation Spatiale des Génomes, Institut Pasteur, CNRS UMR 3525, Université Paris Cité, Paris, France.
Agnès ThierryUnité Régulation Spatiale des Génomes, Institut Pasteur, CNRS UMR 3525, Université Paris Cité, Paris, France.
Romain KoszulUnité Régulation Spatiale des Génomes, Institut Pasteur, CNRS UMR 3525, Université Paris Cité, Paris, France.ORCID 0000-0002-3086-1173
Florian TessonMolecular Diversity of Microbes, Institut Pasteur, CNRS UMR3525, Université Paris Cité, Paris, France.ORCID 0000-0003-4038-1154
Aude BernheimMolecular Diversity of Microbes, Institut Pasteur, CNRS UMR3525, Université Paris Cité, Paris, France.ORCID 0000-0003-0212-777X
David BikardSynthetic Biology, Institut Pasteur, Université Paris Cité, CNRS UMR 6047, Paris, France. david.bikard@pasteur.fr.ORCID 0000-0002-5729-1211
Blake WiedenheftDepartment of Microbiology and Cell Biology, Montana State University, Bozeman, MT, USA. bwiedenheft@gmail.com.ORCID 0000-0001-9297-5304
Artem IsaevThe Center for Molecular and Cellular Biology, Moscow, Russia. tcft18@gmail.com.ORCID 0000-0002-9593-2745

Funding

Research Core (Developmental Research Project Program)P20GM103474 · NIGMS · MONTANA STATE UNIVERSITY - BOZEMAN · PI MARK T QUINN · 2012 to 2026
$60.0M
ChimeraX -- Next Generation Visualization and Analysis Software for Multiscale ModelingR01GM129325 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FERRIN, THOMAS E · 2018 to 2025
$5.2M
Structural and functional understanding of bacterial defense and viral counter defenseR35GM134867 · NIGMS · MONTANA STATE UNIVERSITY - BOZEMAN · PI Blake A Wiedenheft · 2020 to 2026
$3.8M
Mechanisms of CRISPR-mediated immunity and applications beyond editingR00GM147842 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI Andrew Santiago-Frangos · 2024 to 2026
$747k
Mechanisms of CRISPR-mediated immunity and applications beyond editingK99GM147842 · NIGMS · MONTANA STATE UNIVERSITY - BOZEMAN · PI SANTIAGO-FRANGOS, ANDREW · 2022 to 2023
$171k
CRISPR RNA-guided recognition of invading RNA activates a multipronged cell death responseF31GM153146 · NIGMS · MONTANA STATE UNIVERSITY - BOZEMAN · PI BURMAN, NATHANIEL · 2024 to 2025
$73k
NIGMS NIH HHS F31 GM153146NIGMS NIH HHS K99 GM147842NIGMS NIH HHS P20 GM103474NIGMS NIH HHS R00 GM147842NIGMS NIH HHS R01 GM129325NIGMS NIH HHS R35 GM134867
6 · The paper itself

Abstract

Viruses compete with each other for limited cellular resources, and some deliver defence mechanisms that protect the host from competing genetic parasites

Indexed as

BacteriophagesEscherichia coliRNA, TransferViral ProteinsAdenosine TriphosphatasesAdenosine TriphosphateCryoelectron MicroscopyGenome, ViralModels, MolecularProtein MultimerizationRibonucleasesRNA, Transfer, LysAdenosine TriphosphatasesAdenosine TriphosphateRibonucleasesRNA, TransferRNA, Transfer, LysViral Proteins

Identifiers

PMID39111359
PMCPMC11464382

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.